Abstract
Metal-based polymeric compounds have emerged as promising agents in the field of anticancer therapeutics due to their unique properties and multifunctional capabilities. Herein, we provide an overview of the recent advancements and progress made in the development of metal-containing polymeric compounds as potential anticancer agents. The discussion encompasses the metal-based synthetic polymer drug conjugates, natural polymer drug conjugates, metal-based coordination polymers, metallodendrimers, and polymer conjugate with chitosan NPs. Emphasis is placed on the diverse range of 3d transition metals integrated into polymeric architectures to enhance their efficacy, selectivity, and biocompatibility. Furthermore, the key aspects regarding the mechanisms of action, including interactions with cellular components and pathways, are explored, shedding light on their potential as targeted therapies and overcoming drug resistance mechanisms.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Abdalbari FH, Telleria CM (2021) The gold complex auranofin: new perspectives for cancer therapy. Discov Oncol 12:42. https://doi.org/10.1007/s12672-021-00439-0
Abd-El-Aziz A, Abdelghani AA, Mishra AK (2020) Optical and biological properties of metal-containing macromolecules. J Inorg Organomet Polym Mater 30:3–41. https://doi.org/10.1007/s10904-019-01293-y
Ahn J, Miura Y, Yamada N, Chida T, Liu X, Kim A, Sato R, Tsumura R, Koga Y, Yasunaga M, Nishiyama N, Matsumura Y, Cabral H, Kataoka K (2015) Antibody fragment-conjugated polymeric micelles incorporating platinum drugs for targeted therapy of pancreatic cancer. Biomaterials 39:23–30. https://doi.org/10.1016/j.biomaterials.2014.10.069
Ambika S, Arunachalam S, Arunb R, Premkumar K (2013) Synthesis, nucleic acid binding, anticancer and antimicrobial activities of polymer–copper(II) complexes containing intercalative phenanthroline ligand (DPQ). RSC Adv 3:16456–16468. https://doi.org/10.1039/C3RA42512F
Apperley JF (2007) Part I: mechanisms of resistance to imatinib in chronic myeloid leukaemia. Lancet Oncol 8:1018–1029. https://doi.org/10.1016/S1470-2045(07)70342-X
Biswas S, Kumari P, Lakhani PM, Ghosh B (2016) Recent advances in polymeric micelles for anti-cancer drug delivery. Eur J Pharm Sci 83:184–202. https://doi.org/10.1016/j.ejps.2015.12.031
Cheng Z, Li M, Dey R, Chen Y (2021) Nanomaterials for cancer therapy: current progress and perspectives. J Hematol Oncol 14:1–27. https://doi.org/10.1186/s13045-021-01096-0
Cho EJ, Sun B, Doh KO, Wilson EM, Torregrosa-Allen S, Elzey BD, Yeo Y (2015) Intraperitoneal delivery of platinum with in-situ crosslinkable hyaluronic acid gel for local therapy of ovarian cancer. Biomaterials 37:312–319. https://doi.org/10.1016/j.biomaterials.2014.10.039
Coelho JF, Ferreira PC, Alves P, Cordeiro R, Fonseca AC, Gois JR (2010) Drug delivery systems: advanced technologies potentially applicable in personalized treatments, M.H.Gill. EPMA J 1:164–209. https://doi.org/10.1007/s13167-010-0001-x
Corte-Real L, Robalo MP, Marques F, Nogueira G, Avecilla F, Silva TJL, Santos FC, Tomaz AI, Garcia MH, Valente A (2015) The key role of coligands in novel ruthenium(II)-cyclopentadienyl bipyridine derivatives: ranging from non-cytotoxic to highly cytotoxic compounds. J Inorg Biochem 150:148–159. https://doi.org/10.1016/j.**orgbio.2015.06.015
Côrte-Real L, Teixeira RG, Gírio P, Comsa E, Moreno A, Nasr R, Baubichon-Cortay H, Avecilla F, Marques F, Robalo MP, Mendes P, Ramalho JPP, Garcia MH, Falson P, Valente A (2018) Methyl-cyclopentadienyl ruthenium compounds with 2,2′-bipyridine derivatives display strong anticancer activity and multidrug resistance potential. Inorg Chem 57:4629–4639. https://doi.org/10.1016/j.ejmech.2018.12.022
Côrte-Real L, Karas B, Gírio P, Moreno A, Avecilla F, Marques F, Buckley BT, Cooper KR, Doherty C, Falson P, Garcia MH, Valente A (2019) Unprecedented inhibition of P-gp activity by a novel ruthenium-cyclopentadienyl compound bearing a bipyridine-biotin ligand. Eur J Med Chem 163:853–863. https://doi.org/10.1016/j.ejmech.2018.12.022
Crawford S (2013) Is it time for a new paradigm for systemic cancer treatment? Lessons from a century of cancer chemotherapy. Front Pharmacol 4:68. https://doi.org/10.3389/fphar.2013.00068
Del Olmo NS, Maroto-Díaz M, Gómez R, Ortega P, Cangiotti M, Ottaviani MF, de la Mata FJ (2017) Carbosilane metallodendrimers based on copper (II) complexes: synthesis, EPR characterization and anticancer activity. J Inorg Biochem 177:211–218. https://doi.org/10.1016/j.**orgbio.2017.09.023
Druker BJ, Sawyers CL, Kantarjian H, Resta DJ, Reese SF, Ford JM, Capdeville R, Talpaz M (2001) Activity of a specific inhibitor of the BCR-ABL tyrosine kinase in the blast crisis of chronic myeloid leukemia and acute lymphoblastic leukemia with the Philadelphia chromosome. N Engl J Med 344:1038–1042. https://doi.org/10.1056/NEJM200104053441402
Dzhardimalieva GI, Rabinskiy LN, Kydralieva KA, Uflyand IE (2019a) Recent advances in metallopolymer-based drug delivery systems. RSC Adv 9:37009–37051. https://doi.org/10.1039/c9ra06678k
Dzhardimalieva GI, Rabinskiy LN, Kydralieva KA, Uflyand IE (2019b) Recent advances in metallopolymer-based drug delivery systems. RSC Adv 9:37009–37051. https://doi.org/10.1016/j.colsurfb.2019.110596
Ellahioui Y, Prashar S, Gomez-Ruiz S (2017) Anticancer applications and recent investigations of Metallodrugs based on gallium, tin and titanium. Inorganics 5:1–23. https://doi.org/10.3390/inorganics5010004
Elmowafy EM, Tiboni M, Soliman ME (2019) Biocompatibility, biodegradation and biomedical applications of poly(lactic acid)/poly(lactic-co-glycolic acid) micro and nanoparticles. J Pharm Investig 49:347–380. https://doi.org/10.1007/s40005-019-00439-x
Ghezzi M, Pescina S, Padula C, Santi P, Del Favero E, Cantù L, Nicoli S (2021) Polymeric micelles in drug delivery: an insight of the techniques for their characterization and assessment in biorelevant conditions. J Control Release 332:312–336. https://doi.org/10.1016/j.jconrel.2021.02.031
Gil MS, Thambi T, Phan VHG, Kim SH, Lee DS (2017) Injectable hydrogel-incorporated cancer cell-specific cisplatin releasing nanogels for targeted drug delivery. J Mater Chem B 5:7140–7152. https://doi.org/10.1039/C7TB00873B
Hanafy NAN, El-Kemary M, Leporatti S (2018) Micelles structure development as a strategy to improve smart cancer therapy. Cancers 10:238. https://doi.org/10.3390/cancers10070238
Hanif M, Hartinger CG (2018) Anticancer metallodrugs: where is the next cisplatin? Future Med Chem 10:615–617. https://doi.org/10.4155/fmc-2017-0317
He C, Poon C, Chan C, Yamada SD, Lin W (2016) Nanoscale coordination polymers Codeliver chemotherapeutics and siRNAs to eradicate tumors of cisplatin-resistant ovarian cancer. J Am Chem Soc 138:6010–6019. https://doi.org/10.1021/jacs.6b02486
Idrees H, Zohaib S, Zaidi J, Sabir A, Khan R, Zhang X, Hassan SU (2020) A review of biodegradable natural polymer-based nanoparticles for drug delivery applications. Nano 10:1970. https://doi.org/10.3390/nano10101970
Iqbal N, Iqbal N (2014) Imatinib: a breakthrough of targeted therapy in cancer. Chemother Res Pract 2014:357027. https://doi.org/10.1155/2F2014/2F357027
Khan MI, Hossain MI, Hossain MK, Rubel MHK, Hossain KM, Mahfuz AMUB, Anik MI (2022) Recent progress in nanostructured smart drug delivery systems for cancer therapy: a review. ACS Appl Bio Mater 5:971–1012. https://doi.org/10.1021/acsabm.2c00002
Kostova I (2006) Gold coordination complexes as anticancer agents. Anti Cancer Agents Med Chem 6:19–32. https://doi.org/10.2174/187152006774755500
Kowol CR, Heffeter P, Miklos W, Gille L, Trond R, Cappellacci L, Berger W, Keppler BK (2012) Mechanisms underlying reductant-induced reactive oxygen species formation by anticancer copper (II) compounds. J Biol Inorg Chem 17:409–423. https://doi.org/10.1007/s00775-011-0864-x
Kumar RS, Arunachalam S, Periasamy VS, Preethy CP, Riyasdeen A, Akbarsha MA (2008) DNA binding and biological studies of some novel water-soluble polymer–copper(II)–phenanthroline complexes. Eur J Med Chem 43:2082–2091. https://doi.org/10.1016/j.ejmech.2007.09.017
Kumar RS, Periasamy VS, Paul CP, Riyasdeen A, Arunachalam S, Akbarsha MA (2011) Cytotoxic effect of a polymer–copper(II) complex containing2,2-bipyridyl ligand on human lung cancer cells. Med Chem Res 20:726–731. https://doi.org/10.1007/s00044-010-9380-8
Kumar B, Singh S, Skvortsova I, Kumar V (2017) Promising targets in anti-cancer drug development: recent updates. Curr Med Chem 24:4729–4752. https://doi.org/10.2174/0929867324666170331123648
Lago AB, Pino-Cuevas A, Carballo R, Vazquez-Lopez EM (2016) A new metal–organic polymeric system capable of stimuli-responsive controlled release of the drug ibuprofen. Dalton Trans 45:1614–1621. https://doi.org/10.1039/C5DT04031K
Larnaudie SC, Brendel JC, Romero-Canelón I, Sanchez-Cano C, Catrouillet S, Sanchis J, Coverdale JPC, Song J-I, Habtemariam A, Sadler PJ, Jolliffe KA, Perrier S (2018) Cyclic peptide–polymer nanotubes as efficient and highly potent drug delivery systems for organometallic anticancer complexes. Biomacromolecules 19:239–247. https://doi.org/10.1021/acs.biomac.7b01491
Liang S, Duan Y, Zhang J, **ng Z, Chen X, Yang Y, Li Q (2015) Chemically conjugating poly (amidoamine) with chondroitin sulfate to promote CD44-mediated endocytosis for miR-34a delivery. J Control Release 213:e95–e96. https://doi.org/10.1016/j.jconrel.2015.05.159
Ling X, Shen Y, Sun R, Zhang M, Li C, Mao J, **ng J, Sun C, Tu J (2015) Tumor-targeting delivery of hyaluronic acid–platinum (iv) nanoconjugate to reduce toxicity and improve survival. Polym Chem 6:1541–1552. https://doi.org/10.1039/C4PY01592D
Lu M, Chen F, Noy JM, Lu H, Stenzel MH (2017) Enhanced Antimetastatic activity of the ruthenium anticancer drug RAPTA-C delivered in fructose-coated micelles. Macromol Biosci 17:1600513. https://doi.org/10.1002/mabi.201600513
Malafaya PB, Silva GA, Reis RL (2007) Natural-origin polymers as carriers and scaffolds for biomolecules and cell delivery in tissue engineering applications. Adv Drug Deliv Rev 59:207–233. https://doi.org/10.1016/j.addr.2007.03.012
Maroto-Diaz M, Elie BT, Gómez-Sal P, Pérez-Serrano J, Gómez M, Contel R, de la Mata FJ (2016) Synthesis and anticancer activity of carbosilane metallodendrimers based on arene ruthenium (II) complexes. Dalton Trans 45:7049–7066. https://doi.org/10.1039/C6DT00465B
Maroto-Diaz M, Sanz del Olmo N, Muñoz-Moreno L, Bajo AM, Carmena MJ, Gómez R, García-Gallego S, de la Mata FJ (2019) In vitro and in vivo evaluation of first-generation carbosilane arene Ru(II)-metallodendrimers in advanced prostate cancer. Eur Polym J 113:229. https://10.1016/j.eurpolymj.2019.01.047
Medici S, Peana M, Nurchi VM, Lachowicz JI, Crisponi G, Zoroddu MA (2015) Noble metals in medicine: latest advances. Coord Chem Rev 284:329–350. https://doi.org/10.1016/j.ccr.2014.08.002
Michlewska S, Ionov M, Shcharbin D, Maroto-Díaz M, Ramirez RG, de la Mata FJ, Bryszewska M (2017) Ruthenium metallodendrimers with anticancer potential in an acute promyelocytic leukemia cell line (HL60). Eur Polym J 87:39–47. https://10.1016/j.eurpolymj.2016.12.011
Munteanu CR, Suntharalingam K (2015) Advances in cobalt complexes as anticancer agents. Dalton Trans 31:13796–13808. https://doi.org/10.1039/C5DT02101D
Neuse EW (2008) Synthetic polymers as drug-delivery vehicles in medicine. Metal-Based Drugs 2008:1. https://doi.org/10.1155/2008/469531
Nitta SK, Numata K (2013) Biopolymer-based nanoparticles for drug/gene delivery and tissue engineering. Int J Mol Sci 14:1629–1654. https://doi.org/10.3390/ijms14011629
Olszewski U, Hamilton G (2010) A better platinum–based anticancer drug yet to come? Anticancer Agents Med 10:293–301. https://doi.org/10.2174/187152010791162306
Patel P, Vyas N, Raval M (2021) Safety and toxicity issues of polymeric nanoparticles: a serious concern. In: Nanotechnology medicine. Wiley, Hoboken, pp 156–173. https://doi.org/10.1002/9781119769897.ch7
Pathak VM (2017) Navneet, review on the current status of polymer degradation: a microbial approach. Bioresour Bioprocess 4:15. https://doi.org/10.1186/s40643-017-0145-9
Pellei M, Bello FD, Porchia M, Santini C (2021) Zinc coordination complexes as anticancer agents. Coord Chem Rev 445:214088. https://doi.org/10.1016/j.ccr.2021.214088
Peng K, Liang BB, Liu W, Mao ZW (2021) What blocks more anticancer platinum complexes from experiment to clinic: major problems and potential strategies from drug design perspectives. Coord Chem Rev 449:214210. https://doi.org/10.1016/j.ccr.2021.214210
Pramanik A, Laha D, Pramanik P, Karmakar P (2014) A novel drug “copper acetylacetonate” loaded in folic acid-tagged chitosan nanoparticle for efficient cancer cell targeting. J Drug Target 22:23–33. https://doi.org/10.3109/1061186X.2013.832768
Reddy MSB, Ponnamma D, Choudhary R, Sadasivuni KK (2021) A comparative review of natural and synthetic biopolymer composite scaffolds. Polymers 13:1105. https://doi.org/10.3390/polym13071105
Rezaei M, Abbasi A, Dinarvand R, Jeddi-Tehrani M, Janczak J (2018) Design and synthesis of a biocompatible 1D coordination polymer as anti-breast cancer drug carrier, 5-Fu: in vitro and in vivo studies. ACS Appl Mater Interfaces 10:17594–17604. https://doi.org/10.1021/acsami.8b03111
Rodrigues J, Jardim MG, Figueira J, Gouveia M, Toma’s H, Rissanen K (2011) Poly(alkylidenamines) dendrimers as scaffolds for the preparation of low-generation ruthenium based metallodendrimers. New J Chem 35:1938–1943. https://doi.org/10.1039/C1NJ20364A
Rodríguez-Velázquez E, Alatorre-Meda M, J.F. (2015) Mano polysaccharide-based nanobiomaterials as controlled release systems for tissue engineering applications. Curr Pharm Des 21:4837–4850
Sairam AB, Sanmugam A, Pushparaj G, Kumar NM, Sundarapandian S, Balaji M, Nallal KH (2023) Park, toxicity of polymeric Nanodrugs as drug carriers. ACS Chem Health Safe 30:236–250. https://doi.org/10.1021/acs.chas.3c00008
Schepetkin I, Potapov A, Khlebnikov A, Korotkova E, Lukina A, Malovichko G, Kirpotina L, Quinn MT (2006) Decomposition of reactive oxygen species by copper(II) bis(1-pyrazolyl)methane complexes. J Biol Inorg Chem 11:499–513. https://doi.org/10.1007/s00775-006-0101-1
Seifu MF, Nath LK (2019) Polymer-drug conjugates: novel carriers for cancer chemotherapy. Polymer Plastics Technol Mat 58:158–171. https://doi.org/10.1080/03602559.2018.1466172
Shen W, Luan J, Cao L, Sun J, Yu L, Ding J (2015) Thermogelling polymer–platinum(IV) conjugates for Long-term delivery of cisplatin. Biomacromolecules 16:105–115. https://doi.org/10.1021/bm501220a
Shi C, Yu H, Sun D, Ma L, Tang Z, **ao Q, Chen X (2015) Cisplatin-loaded polymeric nanoparticles: characterization and potential exploitation for the treatment of non-small cell lung carcinoma. Acta Biomater 18:68–76. https://doi.org/10.1016/j.actbio.2015.02.009
Shumi G, Desalegan T, Demissie TB, Rmachandran VP, Eswaramoorthy R (2022) Metal complexes in target-specific anticancer therapy: recent trends and challenges. J Chem 2022:1–19. https://doi.org/10.1155/2022/9261683
Sigman DS, Graham DR, D’aurora V, Stern AM (1979) Oxygen–dependent cleavage of DNA by the 1, 10–phenanthroline. Cuprous complex. Inhibition of Escherichia coli DNA polymerase I. J Biol Chem 254:12269–12272
Subhan MA, Yalamarty SSK, Filipczak N, Parveen F, Torchilin VP (2021) Recent advances in tumor targeting via EPR effect for cancer treatment. J Pers Med 11:571. https://doi.org/10.3390/2Fjpm11060571
Sung YK, Kim SW (2020) Recent advances in polymeric drug delivery systems. Biomater Res 24:12. https://doi.org/10.1186/s40824-020-00190-7
Wadhwa S, Mumper RJ (2015) Polymer-drug conjugates for anticancer drug delivery. Crit Rev Ther Drug Carrier Syst 32:215–245. https://doi.org/10.1615/CritRevTherDrugCarrierSyst.2015010174
Wang R-M, Hea N-P, Songa P-F, Hea Y-F, Ding L, Lei Z-Q (2009) Preparation of nano-chitosan Schiff-base copper complexes and their anticancer activity. Polym Adv Technol 20:959–964. https://doi.org/10.1002/pat.1348
Weiss A, Berndsen RH, Dubois M, Muller C (2014) In vivo anti-tumor activity of the organometallic ruthenium(II)-arene complex [Ru(ƞ6-p-cymene)-Cl2(pta)] (RAPTA-C) in human ovarian and colorectal carcinomas. Chem Sci 5:4742–4748. https://doi.org/10.1016/j.ccr.2019.02.017
Wen H, Jung H, Xuhong L (2015) Drug delivery approaches in addressing clinical pharmacology-related issues: opportunities and challenges. AAPS J 17:1327–1340. https://doi.org/10.1208/12248-015-9814-9
Wijdeven RH, Pang B, Assaraf YG, Neefjes J (2016) Old drugs, novel ways out: drug resistance toward cytotoxic chemotherapeutics. Drug Resist Updat 28:65–81. https://doi.org/10.1016/j.drup.2016.07.001
Yang Y, Xu L, Zhu W, Feng L, Liu J, Chen Q, Dong Z, Zhao J, Liu Z, Chen M (2018) One-pot synthesis of pH-responsive charge-switchable PEGylated nanoscale coordination polymers for improved cancer therapy. Biomaterials 156:121–133. https://doi.org/10.1016/j.biomaterials.2017.11.038
Yousuf S, Siddique HR, Arjmand F, Tabassum S (2022) Functionalized graphene oxide loaded GATPT as rationally designed vehicle for cancer-targeted drug delivery. J Drug Deliv Sci Technol 71:103281. https://doi.org/10.1016/j.jddst.2022.103281
Yu H, Tang Z, Zhang D, Song W, Zhang Y, Yang Y, Ahmad Z, Chen X (2015) Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(l-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy. J Control Release 205:89–97. https://doi.org/10.1016/j.jconrel.2014.12.022
Yusuf A, Almotairy ARZ, Henidi H, Alshehri OY, Aldughaim MS (2023) Nanoparticles as drug delivery systems: a review of the implication of nanoparticles’ physicochemical properties on responses in biological systems. Polymers 15:1596. https://doi.org/10.3390/polym15071596
Zashikhina N, Levit M, Dobrodomov A, Gladnev S, Lavrentieva A, Tennikova T, Korzhikova-Vlakh E (2022) Biocompatible nanoparticles based on amphiphilic random polypeptides and glycopolymers as drug delivery systems. Polymers 14:1677. https://doi.org/10.3390/polym14091677
Zhang Z, Wu Y, Kuang G, Liu S, Zhou D, Chen X, **g X, Huang Y (2017a) Pt(IV) prodrug-backboned micelle and DCA loaded nanofibers for enhanced local cancer treatment. J Mater Chem B 5:2115–2125. https://doi.org/10.1039/C7TB00178A
Zhang Z, Li Y, Wan J, Long P, Guo J, Chen G, Wang C (2017b) Preparation of Pt(iv)-crosslinked polymer nanoparticles with an anti-detoxifying effect for enhanced anticancer therapy. Polym Chem 8:2410–2422. https://doi.org/10.1039/C6PY02148D
Zhang Y, Sun T, Jiang C (2018) Biomacromolecules as carriers in drug delivery and tissue engineering. Acta Pharm Sin B 8:34–50. https://doi.org/10.1016/j.apsb.2017.11.005
Zhng W, Zhng Z, Tung CH (2017) Beyond chemotherapeutics: cisplatin as a temporary buckle to fabricate drug-loaded nanogels. Chem Commun 53:779–782. https://doi.org/10.1039/C6CC08230K
Zielińska A, Carreiró F, Oliveira AM, Neves A, Pires B, Venkatesh DN, Durazzo A, Lucarini M, Eder P, Silva AM, Santini A, Souto EB (2020) Polymeric nanoparticles: production, characterization, toxicology and ecotoxicology. Molecules 25:3731. https://doi.org/10.3390/molecules25163731
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2024 The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Arjmand, F., Tabassum, S., Khan, H.Y. (2024). Progress and Future Projections in Metal-Based Polymeric Anticancer Compounds. In: Advances and Prospects of 3-d Metal-Based Anticancer Drug Candidates . Springer, Singapore. https://doi.org/10.1007/978-981-97-0146-9_11
Download citation
DOI: https://doi.org/10.1007/978-981-97-0146-9_11
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-97-0145-2
Online ISBN: 978-981-97-0146-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)